Is gut microbiota of patients with ALS different from that of healthy individuals?
Turkish Journal of Medical Sciences · 01.01.2024 · 54 (3) · 579-587
DOI: 10.55730/1300-0144.5825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 01.01.2024. Verfasst von Zerin Özaydin Aksun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, Ankara University, Ankara, Turkiye. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Several studies shown that alterations of microbiota, increase the risk of neurodegenerative disorders. We aimed to reveal whether there is a difference in the gut microbiota of patients with ALS.Materials and methods: The participants are divided into three groups. Group 1 formed patients with ALS. Healthy family members living in the same house of the patients formed Group 2. Lastly, sex, age-matched healthy people were included in Group 3. Fecal samples were collected in 15 mL falcon tubes and stored at -80 °C. Genomic DNA isolation was performed on samples. Bacterial primers selected from the 16S rRNA region for the bacterial genome and ITS1 and ITS4 (Internal Transcribed Spacer) were used for the identification of DNA. Next generation sequence analysis (NGS), taxonomic analyzes were performed at the level of bacterial phylum, class, order, family, genus, and species. Alpha and beta diversity indexes were used. The Linear Discriminant Analysis (LDA) Effect Size method (LEfSe) was applied to identify a microbial taxon specific to ALS disease.Results: The relative abundances of Succinivibrionaceae and Lachnospiraceae families were significantly lower in patients. The dominant families of patients were Streptococcaceae and Ruminococcaceae, while the dominant families of healthy controls were Bacteroidaceae, Succinivibrionaceae. LEfSe analysis showed four families (Atopobiaceae, Actinomycetaceae, Erysipelatoclostridiaceae, Peptococcacceae) differed significantly between the patients and healthy controls (LDA values> 2.5, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Medicine, Ankara University, Ankara, Turkiye.
- Department of Microbiology, Faculty of Medicine, Gazi University, Ankara, Turkiye.
ORCID-Profile: Zerin Özaydin Aksun, Seyda Erdoğan, Ayşe Kalkanci, Elif Ayça Şahin, Tuğba Çuhadar, H Özden Şener
Zitieren
APA
Özaydin Aksun, Z., Erdoğan, S., Kalkanci, A., Şahin, E. A., Çuhadar, T., & Şener, H. Ö. (2024). Is gut microbiota of patients with ALS different from that of healthy individuals?. Turkish Journal of Medical Sciences, 54(3), 579-587. https://doi.org/10.55730/1300-0144.5825
Vancouver
Özaydin Aksun Z, Erdoğan S, Kalkanci A, Şahin EA, Çuhadar T, Şener HÖ. Is gut microbiota of patients with ALS different from that of healthy individuals?. Turkish Journal of Medical Sciences. 2024;54(3):579-587. doi:10.55730/1300-0144.5825
BibTeX
@article{zaydinAksun2024,
author = {Özaydin Aksun, Zerin and Erdoğan, Seyda and Kalkanci, Ayşe and Şahin, Elif Ayça and Çuhadar, Tuğba and Şener, H Özden},
title = {Is gut microbiota of patients with ALS different from that of healthy individuals?},
journal = {Turkish Journal of Medical Sciences},
year = {2024},
volume = {54},
number = {3},
pages = {579--587},
doi = {10.55730/1300-0144.5825}
}
EUVIMED